Načítá se...

The clinical profile of benralizumab in the management of severe eosinophilic asthma

Despite several therapeutic choices, 10–20% of patients with severe uncontrolled asthma do not respond to maximal best standard treatments, leading to a healthcare expenditure of up to 80% of overall costs for asthma. Today, there are new important therapeutic strategies, both pharmacological and in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Adv Respir Dis
Hlavní autoři: Menzella, Francesco, Lusuardi, Mirco, Galeone, Carla, Facciolongo, Nicola, Zucchi, Luigi
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5933597/
https://ncbi.nlm.nih.gov/pubmed/27612492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465816667659
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!